Heron Therapeutics
(HRTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2003 | 12-2002 | 09-2002 | 06-2002 | 03-2002 | |
| Sales | 1,106 | 1,709 | 1,041 | 968 | 952 |
| Gross Profit | 1,106 | 1,709 | 1,041 | 968 | 952 |
| Operating Expenses | 2,980 | 2,263 | 2,518 | 2,685 | 2,257 |
| Operating Income | -1,874 | -554 | -1,477 | -1,717 | -1,305 |
| Other Income | 76 | 141 | 138 | 175 | 204 |
| Pre-tax Income | -1,798 | -413 | -1,339 | -1,542 | -1,101 |
| Net Income Continuous | -1,798 | -413 | -1,339 | -1,542 | -1,101 |
| Net Income Discontinuous | 1,832 | 186 | 287 | 49 | 95 |
| Net Income | $34 | $-227 | $-1,052 | $-1,493 | $-1,006 |
| EPS Basic Total Ops | 0.13 | -1.60 | -4.00 | -5.60 | -4.00 |
| EPS Basic Continuous Ops | -7.20 | -1.60 | -5.60 | -6.40 | -4.00 |
| EPS Basic Discontinuous Ops | 7.16 | 0.73 | 1.12 | 0.19 | 0.37 |
| EPS Diluted Total Ops | 0.13 | -1.60 | -4.00 | -5.60 | -4.00 |
| EPS Diluted Continuous Ops | -7.20 | -1.60 | -5.60 | -6.40 | -4.00 |
| EPS Diluted Discontinuous Ops | 7.14 | 0.73 | 1.12 | 0.19 | 0.37 |
| EBITDA(a) | $-1,780 | $-431 | $-1,391 | $-1,568 | $-1,192 |